Volker Wacheck
Taiho Oncology (United States)(US)
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Lung Cancer Treatments and Mutations, Fibroblast Growth Factor Research, Liver physiology and pathology, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Futibatinib for FGFR2 -Rearranged Intrahepatic Cholangiocarcinoma(2023)491 cited
- → Chemosensitisation of malignant melanoma by BCL2 antisense therapy(2000)481 cited
- → Mcl-1 overexpression in hepatocellular carcinoma: A potential target for antisense therapy(2005)252 cited
- → Identification of mcl-1 as a BCR/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides(2004)252 cited
- → Effects of Betulinic Acid Alone and in Combination with Irradiation in Human Melanoma Cells(2000)174 cited
- → Expression of the target receptor CD33 in CD34+/CD38−/CD123+ AML stem cells(2006)156 cited
- → Mammalian Target of Rapamycin Pathway Activity in Hepatocellular Carcinomas of Patients Undergoing Liver Transplantation(2007)153 cited
- → A Novel Type of Influenza Vaccine: Safety and Immunogenicity of Replication‐Deficient Influenza Virus Created by Deletion of the Interferon Antagonist NS1(2009)130 cited
- → Betulinic acid: A new cytotoxic compound against malignant head and neck cancer cells(2003)113 cited
- → Compact, broad-bandwidth fiber laser for sub-2-µm axial resolution optical coherence tomography in the 1300-nm wavelength region(2003)109 cited